<DOC>
	<DOCNO>NCT00533195</DOCNO>
	<brief_summary>The purpose study compare efficacy , tolerability remission duration UVA 1 therapy versus 5-MOP UVA photochemotherapy patient severe generalize atopic dermatitis .</brief_summary>
	<brief_title>Comparison UVA1 Phototherapy Versus Photochemotherapy Patients With Severe Generalized Atopic Dermatitis</brief_title>
	<detailed_description>The patient randomize assigned UVA 1 phototherapy 5-MOP UVA photochemotherapy first therapy . Besides emollient additional treatment allow . First detailed history inclusive drug history gather . The skin type determine clinical photo make . Prior 5-MOP UVA photochemotherapy ophthalmological examination , blood cell count blood chemistry routinely perform . A determination serum level 5 MOP routinely make minimal phototoxic dose ( MPD ) determination start 5-MOP UVA photochemotherapy . The serum level total Ig E eosinophilic cationic protein ( ECP ) additionally determine start end therapy . In patient receive 5-MOP UVA photochemotherapy reliable eye protection wear photoprotective glass treatment day take 5-MOP night take place . The skin patient expose direct sun light artificial UV source day irradiation . A determination SCORAD Score perform blind investigator baseline , 10 15 irradiation well every follow-up visit month 1 , 3 , 6 12 . A clinical photo make begin therapy , end well every follow-up visit . In case relapse ( SCORAD Score &gt; 50 % initial value ) , patient ' request premature resumption therapy ( despite SCORAD Score &gt; 50 % ) patient receive treatment perform . That mean , patient treat 5-MOP UVA first therapy receive UVA 1 phototherapy vice versa . The minimum interval two therapy least 1 month except case complete non response first therapy . Irradiation protocol UVA 1 phototherapy : Irradiation 5 x week 3 week ( altogether 15 exposure ) Determination UVA 1 MED prior treatment Start 1 MED MED &lt; 70 J/cm2 . Increase dose 20 % every time erythematous reaction good tolerability maximal dose 70 J/cm2 . Irradiation protocol 5-MOP UVA photochemotherapy : Irradiation 3 x week 5 week ( altogether 15 exposure ) Intake 5-methoxypsoralen ( Geralen ) 2 hour prior irradiation dose 1.2 mg/kg Determination minimal phototoxic dose ( MPD ) prior treatment Determination 5-MOP serum level MPD test Start 70 % MPD , dose increment first week . From second week increase UVA dose 20 % erythematous response ( respectively 10 % light erythemal reaction ) , early 96 hour last increment .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>5-methoxypsoralen</mesh_term>
	<mesh_term>Methoxsalen</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Patients severe generalize atopic dermatitis ( SCORAD Score &gt; 45 ) Patients old 18 year SCORAD Score &lt; 45 Pregnant lactate woman Patients severe general disease Abnormal UVA sensitivity Intake photosensitizing drug Local corticosteroid treatment &lt; 2 week enter study Photo ( chemo ) therapy systemic treatment atopic dermatitis &lt; 4 week study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>UVA1</keyword>
	<keyword>PUVA</keyword>
	<keyword>atopic dermatitis</keyword>
</DOC>